Medline, Humana, Stryker, Gilead Sciences, Medtronic, Boston Scientific, and HCA Healthcare are the seven Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies involved in healthcare, such as pharmaceutical and biotech firms, medical-device makers, and healthcare providers. Investors may buy them to gain exposure to the medical sector, whose performance can be affected by factors such as research results, regulation, and healthcare demand. These companies had the highest dollar trading volume of any Medical stocks within the last several days.
Medline (MDLN)
Our mission is to make healthcare run better by delivering improved clinical, financial, and operational outcomes. We are the largest provider of medical-surgical (“med-surg”) products and supply chain solutions serving all points of care, based on total net sales of med-surg products. We deliver mission-critical products used daily across the full range of care settings, from hospitals and surgery centers to physician offices and post-acute facilities.
NASDAQ MDLN traded up $1.61 during trading hours on Wednesday, hitting $39.29. 26,867,035 shares of the company's stock traded hands, compared to its average volume of 7,883,077. Medline has a 52 week low of $31.37 and a 52 week high of $50.88. The firm has a market capitalization of $51.68 billion and a P/E ratio of 89.22. The company has a current ratio of 4.04, a quick ratio of 2.51 and a debt-to-equity ratio of 0.65. The business's fifty day moving average price is $35.39 and its two-hundred day moving average price is $39.31.
Read Our Latest Research Report on MDLN
Humana (HUM)
Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Shares of HUM stock traded down $45.96 during mid-day trading on Wednesday, reaching $397.38. 1,519,769 shares of the company's stock traded hands, compared to its average volume of 1,650,447. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.65 and a current ratio of 1.65. The firm has a market capitalization of $47.72 billion, a PE ratio of 38.78, a price-to-earnings-growth ratio of 2.20 and a beta of 0.65. Humana has a 12 month low of $163.11 and a 12 month high of $462.87. The firm has a 50 day moving average price of $410.55 and a two-hundred day moving average price of $319.48.
Read Our Latest Research Report on HUM
Stryker (SYK)
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.
NYSE SYK traded up $2.10 on Wednesday, reaching $319.64. 1,013,789 shares of the stock were exchanged, compared to its average volume of 2,523,127. The company has a current ratio of 2.18, a quick ratio of 1.30 and a debt-to-equity ratio of 0.60. Stryker has a one year low of $267.00 and a one year high of $389.33. The firm has a market capitalization of $121.69 billion, a PE ratio of 34.04, a PEG ratio of 2.13 and a beta of 0.78. The company's 50-day simple moving average is $293.26 and its two-hundred day simple moving average is $322.17.
Read Our Latest Research Report on SYK
Gilead Sciences (GILD)
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis.
Gilead Sciences stock traded down $0.87 during mid-day trading on Wednesday, hitting $169.39. The stock had a trading volume of 1,742,831 shares, compared to its average volume of 6,764,680. Gilead Sciences has a one year low of $116.88 and a one year high of $176.58. The company has a current ratio of 1.38, a quick ratio of 1.22 and a debt-to-equity ratio of 1.84. The firm has a market capitalization of $210.11 billion, a P/E ratio of -53.61 and a beta of 0.35. The firm's 50 day moving average is $155.90 and its 200 day moving average is $142.09.
Read Our Latest Research Report on GILD
Medtronic (MDT)
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
Shares of NYSE:MDT traded down $1.18 during trading on Wednesday, hitting $101.14. 2,720,416 shares of the company's stock were exchanged, compared to its average volume of 11,097,564. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.07 and a quick ratio of 1.54. Medtronic has a 52-week low of $73.31 and a 52-week high of $106.33. The business's 50-day simple moving average is $94.09 and its 200 day simple moving average is $88.49. The company has a market cap of $129.37 billion, a price-to-earnings ratio of 24.93, a PEG ratio of 2.41 and a beta of 0.56.
Read Our Latest Research Report on MDT
Boston Scientific (BSX)
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system.
BSX traded up $0.58 during trading on Wednesday, hitting $43.61. 5,628,357 shares of the company traded hands, compared to its average volume of 18,625,074. The company has a current ratio of 1.36, a quick ratio of 0.81 and a debt-to-equity ratio of 0.42. The company has a market cap of $63.21 billion, a PE ratio of 18.50, a P/E/G ratio of 1.29 and a beta of 0.60. The stock's 50-day simple moving average is $43.87 and its two-hundred day simple moving average is $54.00. Boston Scientific has a 1 year low of $39.57 and a 1 year high of $101.91.
Read Our Latest Research Report on BSX
HCA Healthcare (HCA)
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Shares of HCA traded down $16.70 during midday trading on Wednesday, hitting $484.49. 493,198 shares of the company traded hands, compared to its average volume of 1,342,151. The stock has a market cap of $101.20 billion, a price-to-earnings ratio of 16.06, a PEG ratio of 1.71 and a beta of 1.11. The firm has a 50 day moving average of $456.91 and a 200-day moving average of $446.11. HCA Healthcare has a 52 week low of $353.99 and a 52 week high of $556.52.
Read Our Latest Research Report on HCA
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Medline, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Medline wasn't on the list.
While Medline currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.